E.‐B. Bröcker

2.5k total citations
52 papers, 1.8k citations indexed

About

E.‐B. Bröcker is a scholar working on Oncology, Immunology and Dermatology. According to data from OpenAlex, E.‐B. Bröcker has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Immunology and 13 papers in Dermatology. Recurrent topics in E.‐B. Bröcker's work include Immunotherapy and Immune Responses (13 papers), Autoimmune Bullous Skin Diseases (7 papers) and Urticaria and Related Conditions (6 papers). E.‐B. Bröcker is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Autoimmune Bullous Skin Diseases (7 papers) and Urticaria and Related Conditions (6 papers). E.‐B. Bröcker collaborates with scholars based in Germany, United States and Netherlands. E.‐B. Bröcker's co-authors include Jürgen C. Becker, D. J. Ruiter, G. Zwadlo, Ulrich Feige, Clemens Sorg, D. B. v. Bassewitz, Axel Trautmann, Peter Friedl, Kurt S. Zänker and Andreas Schwinn and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

E.‐B. Bröcker

51 papers receiving 1.7k citations

Peers

Countries citing papers authored by E.‐B. Bröcker

Since Specialization

Citations

This map shows the geographic impact of E.‐B. Bröcker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.‐B. Bröcker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.‐B. Bröcker more than expected).

Fields of papers citing papers by E.‐B. Bröcker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.‐B. Bröcker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.‐B. Bröcker. The network helps show where E.‐B. Bröcker may publish in the future.

Co-authorship network of co-authors of E.‐B. Bröcker

This figure shows the co-authorship network connecting the top 25 collaborators of E.‐B. Bröcker. A scholar is included among the top collaborators of E.‐B. Bröcker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.‐B. Bröcker. E.‐B. Bröcker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adjuvant Treatment of Recalcitrant Bullous Pemphigoid with Immunoadsorption 2012 ·Dermatology ·(unknown), E.‐B. Bröcker, Erdwine Klinker, Johanna Stoevesandt, Sandrine Benoit	11
2	Occlusive Treatment Enhances Efficacy of Tacrolimus 0.1% Ointment in Adult Patients with Vitiligo: Results of a Placebo-controlled 12-month Prospective Study 2008 ·Acta Dermato Venereologica ·A. Hartmann, E.‐B. Bröcker, Henning Hamm	48
3	Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG) 2008 ·Annals of Oncology ·Konstanze Spieth, Roland Kaufmann, Reinhard Dummer, Claus Garbe, Jürgen C. Becker, Axel Hauschild, Wolfgang Tilgen, Selma Ugurel, Michael Beyeler, E.‐B. Bröcker, Katharina C. Kaehler, Claudia Pföhler, Jens Gille, Ulrike Leiter, Dirk Schadendorf	23
4	Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial 2007 ·Melanoma Research ·Albrecht Reichle, Thomas Vogt, Brigitte Coras, (unknown), (unknown), Uwe Trefzer, Erwin Schultz, Anna Berand, E.‐B. Bröcker, Michael Landthaler, Reinhard Andreesen	33
5	Pemphigus vegetans mit autoantikorpern gegen rekombinantes desmoglein 3 2000 ·Aktuelle Dermatologie ·(unknown), (unknown), Masayuki Amagai, E.‐B. Bröcker, Detlef Zillikens	1
6	Klinik und Immunpathologie bei 48 Patienten mit Pemphigus 2000 ·Der Hautarzt ·(unknown), (unknown), Masayuki Amagai, Berthold Rzany, E.‐B. Bröcker, Detlef Zillikens	9
7	Streifen- und wirbelförmige nävoide Hypermelanose : Fallbeschreibung und Literaturübersicht 1998 ·Der Hautarzt ·U. Hofmann, Nicola Wagner, T. Grimm, E.‐B. Bröcker, Henning Hamm	1
8	Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis 1998 ·Archives of Dermatological Research ·Wolfgang Dummer, Christian Rosé, E.‐B. Bröcker	23
9	Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. 1998 ·Journal of Clinical Oncology ·(unknown), Christian Conradt, Sewa S. Legha, D. Khayat, Carmen Scheibenbogen, N. Thatcher, S.H. Goey, Martin Gore, Thierry Dorval, Barry W. Hancock, Cornelis J.A. Punt, Reinhard Dummer, M. F. Avril, E.‐B. Bröcker, A. Benhammouda, Alexander M.M. Eggermont, Maria Pritsch	160
10	Adult Rhabdomyoma of the Lip 1998 ·American Journal of Dermatopathology ·Boris C. Bastian, E.‐B. Bröcker	10
11	Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene 1997 ·Journal of Molecular Medicine ·Georg Stingl, E.‐B. Bröcker, Roland Mertelsmann, K. Wolff, S. Schreiber, Eckhart Kämpgen, Achim Schneeberger, Jiri Trcka, U. Brennscheidt, Hendrik Veelken, Max L. Birnstiel, Kurt Zatloukal, Gerd Maass, Ernst Wagner, Michael Buschle, (unknown), Harald Weber, Thor Voigt	11
12	Differential Expression of Chemokines in Patients with Localized and Diffuse Cutaneous American Leishmaniasis 1996 ·The Journal of Infectious Diseases ·Uwe Ritter, Heidrun Moll, Tamás Laskay, E.‐B. Bröcker, (unknown), (unknown), R. Gillitzer	105
13	Primary Neuroendocrine Carcinoma of the Skin with an Unusual Follicular Lymphocytic Infiltrate of the Dermis 1996 ·American Journal of Dermatopathology ·Boris C. Bastian, Hans Kreipe, E.‐B. Bröcker	10
14	Lymphocyte-Mediated Alopecia in C57BL/6 Mice Following Successful Immunotherapy for Melanoma 1996 ·Journal of Investigative Dermatology ·Jürgen C. Becker, Nissi Varki, E.‐B. Bröcker, Ralph A. Reisfeld	34
15	Interferon α2b and Fotemustine in Patients with Disseminated Melanoma 1995 ·Oncology Research and Treatment ·Ulrich R. Kleeberg, (unknown), E.‐B. Bröcker, (unknown), R Châtelain, W. Queißer, M. Westerhausen, B. Rothe, (unknown), Lutz Edler	1
16	Frequency ofTrichophyton rubrumin tinea capitis 1995 ·Mycoses ·Andreas Schwinn, (unknown), E.‐B. Bröcker	38
17	Inhibition of Human Skin Phospholipase A2 by “Lipocortins” Is an Indirect Effect of Substrate/Lipocortin Interaction 1993 ·Journal of Investigative Dermatology ·Boris C. Bastian, (unknown), A. Seekamp, Jürgen Römisch, Eric-Paul Pâques, E.‐B. Bröcker	24
18	Lesion-Specific Activation of Cloned Human Tumor-Infiltrating Lymphocytes by Autologous Tumor Cells: Induction of Proliferation and Cytokine Production 1993 ·Journal of Investigative Dermatology ·Jürgen C. Becker, Andreas Schwinn, Reinhard Dummer, Günter Burg, E.‐B. Bröcker	11
19	Validity of the histopathological criteria used for diagnosing dysplastic naevi 1993 ·European Journal of Cancer ·P.E.J. de Wit, (unknown), D. J. Ruiter, R Bondi, E.‐B. Bröcker, J. P. Césarini, Nina Hastrup, K Hou-Jensen, R.M. MACKIE, E. Scheffer, L. Suter, Carmelo Urso	65
20	Identification of a Melanoma Progression Antigen as Integrin VLA-2 1991 ·Journal of Investigative Dermatology ·Christophe Klein, (unknown), Dieter Kaufmann, Lutz Weber, E.‐B. Bröcker	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact